Boeing suspending 787 production at South Carolina plant
Boeing Co said on Monday it will temporarily suspend production of its 787 airplane at its facilities in South Carolina amid the coronavirus pandemic.
Boeing Co said on Monday it will temporarily suspend production of its 787 airplane at its facilities in South Carolina amid the coronavirus pandemic.
Boeing Co said on Monday it would suspend production of its 787 airplane at its facilities in South Carolina amid the coronavirus pandemic. Boeing production will be suspended until further notice after the second shift on Wednesday. On Sunday, the largest U.S. planemaker indefinitely extended the halt of its production operations at its Washington state facilities. …read more […]
Airbnb said on Monday private-equity firms Silver Lake and Sixth Street Partners would invest $1 billion in the U.S. home rental company through a combination of debt and equity.
U.S. President Donald Trump has been pushing for the use of an anti-malarial drug hydroxychloroquine against the coronavirus, and one prominent doctor says that could be a problem given the lack of data available. …read more […]
Lufthansa will discuss permanently grounding its Germanwings low-cost airline unit at a management board meeting on Tuesday, two sources familiar with the matter told Reuters.
U.S. stocks rocketed higher on Monday, with each of the major indexes rallying at least 7%, after a fall in the daily death toll in New York, the country’s biggest coronavirus hot spot, fueled optimism a leveling off of the pandemic was on the horizon.
With their sales hammered by the coronavirus outbreak, car makers Fiat Chrysler and Peugeot’s owner PSA have postponed their shareholder meetings and are looking at ways to boost cash reserves ahead of their planned merger.
U.S. insurer Allstate Corp said on Monday it would return more than $600 million in auto insurance premiums to customers as many Americans drive less due to “shelter-in-place” orders to curb the coronavirus outbreak.
British drugmaker GlaxoSmithKline (GSK) and Vir Biotechnology Inc (VIR) on Monday announced a partnership to develop potential antibody treatments for COVID-19, the disease caused by the coronavirus.As part of the collaboration agreement GSK will make an investment in Vir of $250 million, priced at $37.73, representing a 10% premium to the closing share price on March 27, 2020, according to the announcement. Vir’s shares soared as much as 34% rising to around $39 in early U.S. trading following the news of GSK’s investment.Wall Street analysts take a cautious stance on Vir’s stock. The Hold analyst consensus rating is based on …read more […]
With a market cap of a miniscule $10.16 million, you can firmly place biotech Capricor Therapeutics (CAPR) in the nano cap section. Although, according to one analyst, if recent developments are anything to go by, the Beverly Hills, California based company won’t be in the small fry category for much longer.H.C. Wainwright’s Joseph Pantginis reiterated a Buy on Capricor along with a $9.00 price target. The implication for investors? Potential upside of a humungous 737%. (To watch Pantginis’s track record, click here)So, what is driving an analyst to set such an extravagant target for such a tiny player? Well, among …read more […]
On Monday, workers at an Amazon warehouse in Staten Island walked off the job for a second time, just one week after holding an initial strike, citing continued coronavirus fears amid 26 cases of the virus at the warehouse. …read more […]
World stock markets jumped on Monday, encouraged by a slowdown in coronavirus-related deaths and new cases in some global hot spots, oil prices tumbled again due to a delay in talks between Saudi Arabia and Russia to cut supply.
Honda Motor Co and Fiat Chrysler Automobiles NV said on Monday they will extend their auto production shutdown in the United States and Canada to all of April.
8×8 CEO Vik Verma joins Yahoo Finance’s Seana Smith to discuss the company’s increase in usage amid the COVID-19 pandemic, as Zoom encounters concerns over its security and privacy. …read more […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.